Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of YHP2508B and YHR2602 in Healthy Subjects
NCT07912840Phase 1Recruiting
- Sponsor
- Yuhan
- Start
- Oct 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of YHP2508B (2 arms), sponsored by Yuhan. Primary endpoints: Area under the plasma drug concentration-time curve and Maximum plasma concentration. Started Oct 2026; status: recruiting.
02
Drugs
YHP2508B
Beyond the preview
Go deeper on NCT07912840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07912840.